Biotech Startups and Gene Therapy for Hearing Loss

Sensorion, a biotechnology company, is participating in the ARO Midwinter Meeting to present its gene therapy programs for hearing loss disorders. The company's focus is on developing treatments for hereditary forms of deafness, including SENS-501 for otoferlin-related deafness and GJB2-GT for GJB2-related deafness. Additionally, the article provides a directory of startups in the biotech sector in Japan, highlighting 395 unlisted startups with outstanding technologies and business models. Abacus Group's Meena Jeenarain has been recognized for promoting female representation in technology and data disciplines. The 'Directory of Biotech Startups in Japan 2021-2022' features 395 selected startups with promising futures in the biotech sector.